HEADER OXIDOREDUCTASE, TRANSFERASE 13-JUN-08 3DG8
TITLE QUADRUPLE MUTANT (N51I+C59R+S108N+I164L) PLASMODIUM FALCIPARUM
TITLE 2 DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE (PFDHFR-TS) COMPLEXED
TITLE 3 WITH RJF670, NADPH, AND DUMP
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: BIFUNCTIONAL DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE;
COMPND 3 CHAIN: A, B;
COMPND 4 FRAGMENT: RESIDUES 1-280;
COMPND 5 EC: 1.5.1.3, 2.1.1.45;
COMPND 6 ENGINEERED: YES;
COMPND 7 MUTATION: YES;
COMPND 8 MOL_ID: 2;
COMPND 9 MOLECULE: BIFUNCTIONAL DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE;
COMPND 10 CHAIN: C, D;
COMPND 11 FRAGMENT: RESIDUES 281-608;
COMPND 12 EC: 1.5.1.3, 2.1.1.45;
COMPND 13 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: PLASMODIUM FALCIPARUM;
SOURCE 3 ORGANISM_TAXID: 5833;
SOURCE 4 STRAIN: V1/S;
SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562;
SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3);
SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;
SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET17B;
SOURCE 10 MOL_ID: 2;
SOURCE 11 ORGANISM_SCIENTIFIC: PLASMODIUM FALCIPARUM;
SOURCE 12 ORGANISM_TAXID: 5833;
SOURCE 13 STRAIN: V1/S;
SOURCE 14 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 15 EXPRESSION_SYSTEM_TAXID: 562;
SOURCE 16 EXPRESSION_SYSTEM_STRAIN: BL21(DE3);
SOURCE 17 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;
SOURCE 18 EXPRESSION_SYSTEM_PLASMID: PET17B
KEYWDS ALPHA-BETA, METHYLTRANSFERASE, OXIDOREDUCTASE, TRANSFERASE
EXPDTA X-RAY DIFFRACTION
AUTHOR T.DASGUPTA,P.CHITNUMSUB,C.MANEERUTTANARUNGROJ,S.KAMCHONWONGPAISAN,
AUTHOR 2 S.NICHOLS,T.M.LYONS,J.TIRADO-RIVES,W.L.JORGENSEN,Y.YUTHAVONG,
AUTHOR 3 K.S.ANDERSON
REVDAT 4 30-AUG-23 3DG8 1 REMARK
REVDAT 3 20-OCT-21 3DG8 1 REMARK SEQADV
REVDAT 2 25-OCT-17 3DG8 1 REMARK
REVDAT 1 27-JAN-09 3DG8 0
JRNL AUTH T.DASGUPTA,P.CHITNUMSUB,S.KAMCHONWONGPAISAN,
JRNL AUTH 2 C.MANEERUTTANARUNGROJ,S.E.NICHOLS,T.M.LYONS,J.TIRADO-RIVES,
JRNL AUTH 3 W.L.JORGENSEN,Y.YUTHAVONG,K.S.ANDERSON
JRNL TITL EXPLOITING STRUCTURAL ANALYSIS, IN SILICO SCREENING, AND
JRNL TITL 2 SERENDIPITY TO IDENTIFY NOVEL INHIBITORS OF DRUG-RESISTANT
JRNL TITL 3 FALCIPARUM MALARIA.
JRNL REF ACS CHEM.BIOL. V. 4 29 2009
JRNL REFN ISSN 1554-8929
JRNL PMID 19146480
JRNL DOI 10.1021/CB8002804
REMARK 2
REMARK 2 RESOLUTION. 2.58 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : CNS
REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE-
REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU,
REMARK 3 : READ,RICE,SIMONSON,WARREN
REMARK 3
REMARK 3 REFINEMENT TARGET : NULL
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.58
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 49.43
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL
REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL
REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 97.6
REMARK 3 NUMBER OF REFLECTIONS : 45609
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING SET) : 0.199
REMARK 3 FREE R VALUE : 0.239
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000
REMARK 3 FREE R VALUE TEST SET COUNT : 2321
REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : NULL
REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL
REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL
REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL
REMARK 3 BIN R VALUE (WORKING SET) : NULL
REMARK 3 BIN FREE R VALUE : NULL
REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL
REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL
REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 9097
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 170
REMARK 3 SOLVENT ATOMS : 260
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : 39.40
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 46.26
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : 9.23000
REMARK 3 B22 (A**2) : -2.12900
REMARK 3 B33 (A**2) : -7.10200
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : 0.00000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.29
REMARK 3 ESD FROM SIGMAA (A) : 0.23
REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00
REMARK 3
REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.34
REMARK 3 ESD FROM C-V SIGMAA (A) : 0.29
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 BOND LENGTHS (A) : 0.240
REMARK 3 BOND ANGLES (DEGREES) : 1.600
REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.90
REMARK 3 IMPROPER ANGLES (DEGREES) : 1.190
REMARK 3
REMARK 3 ISOTROPIC THERMAL MODEL : ISOTROPIC
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA
REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL
REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL
REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL
REMARK 3
REMARK 3 BULK SOLVENT MODELING.
REMARK 3 METHOD USED : NULL
REMARK 3 KSOL : NULL
REMARK 3 BSOL : 36.44
REMARK 3
REMARK 3 NCS MODEL : NULL
REMARK 3
REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT
REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL
REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL
REMARK 3
REMARK 3 PARAMETER FILE 1 : CNS_TOPPAR:PROTEIN_REP.PARAM
REMARK 3 PARAMETER FILE 2 : LIGANDS_1.PARAM
REMARK 3 PARAMETER FILE 3 : CNS_TOPPAR:WATER_REP.PARAM
REMARK 3 PARAMETER FILE 4 : NULL
REMARK 3 TOPOLOGY FILE 1 : NULL
REMARK 3 TOPOLOGY FILE 2 : NULL
REMARK 3 TOPOLOGY FILE 3 : NULL
REMARK 3 TOPOLOGY FILE 4 : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 3DG8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 17-JUN-08.
REMARK 100 THE DEPOSITION ID IS D_1000047999.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 10-AUG-07
REMARK 200 TEMPERATURE (KELVIN) : 100.0
REMARK 200 PH : 4.6
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : NSRRC
REMARK 200 BEAMLINE : BL13B1
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.00000
REMARK 200 MONOCHROMATOR : SI(111)
REMARK 200 OPTICS : MIRRORS
REMARK 200
REMARK 200 DETECTOR TYPE : CCD
REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO, HKL-2000
REMARK 200 DATA SCALING SOFTWARE : SCALEPACK
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 45609
REMARK 200 RESOLUTION RANGE HIGH (A) : 2.560
REMARK 200 RESOLUTION RANGE LOW (A) : 50.000
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 97.6
REMARK 200 DATA REDUNDANCY : 4.200
REMARK 200 R MERGE (I) : 0.06600
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 16.5000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.56
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.65
REMARK 200 COMPLETENESS FOR SHELL (%) : 95.0
REMARK 200 DATA REDUNDANCY IN SHELL : 4.10
REMARK 200 R MERGE FOR SHELL (I) : 0.26500
REMARK 200 R SYM FOR SHELL (I) : 0.26500
REMARK 200 <I/SIGMA(I)> FOR SHELL : 6.360
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS
REMARK 200 SOFTWARE USED: CNS
REMARK 200 STARTING MODEL: PDB ENTRY 1J3K
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 50.80
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.52
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 4000, NH4OAC, PH 4.6, MICROBATCH,
REMARK 280 TEMPERATURE 297K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X+1/2,-Y,Z+1/2
REMARK 290 3555 -X,Y+1/2,-Z+1/2
REMARK 290 4555 X+1/2,-Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 28.25800
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 82.59150
REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 77.70200
REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 82.59150
REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 28.25800
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 77.70200
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1, 2
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 300 REMARK: THE BIOLOGICAL UNIT IS THE SAME AS ASYMMETRIC UNIT.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 1820 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 28690 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -8.4 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350
REMARK 350 BIOMOLECULE: 2
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 1840 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 28900 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -8.5 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 VAL A 86
REMARK 465 ASP A 87
REMARK 465 ASN A 88
REMARK 465 VAL A 89
REMARK 465 ASN A 90
REMARK 465 ASP A 91
REMARK 465 MET A 92
REMARK 465 PRO A 93
REMARK 465 ASN A 94
REMARK 465 SER A 95
REMARK 465 LYS A 232
REMARK 465 MET A 233
REMARK 465 LEU A 234
REMARK 465 ASN A 235
REMARK 465 GLU A 236
REMARK 465 GLN A 237
REMARK 465 ASN A 238
REMARK 465 CYS A 239
REMARK 465 ILE A 240
REMARK 465 LYS A 241
REMARK 465 GLY A 242
REMARK 465 GLU A 243
REMARK 465 GLU A 244
REMARK 465 LYS A 245
REMARK 465 ASN A 246
REMARK 465 ASN A 247
REMARK 465 ASP A 248
REMARK 465 MET A 249
REMARK 465 PRO A 250
REMARK 465 LEU A 251
REMARK 465 LYS A 252
REMARK 465 ASN A 253
REMARK 465 ASP A 254
REMARK 465 ASP A 255
REMARK 465 LYS A 256
REMARK 465 ASP A 257
REMARK 465 THR A 258
REMARK 465 CYS A 259
REMARK 465 HIS A 260
REMARK 465 MET A 261
REMARK 465 LYS A 262
REMARK 465 LYS A 263
REMARK 465 LEU A 264
REMARK 465 THR A 265
REMARK 465 GLU A 266
REMARK 465 PHE A 267
REMARK 465 TYR A 268
REMARK 465 LYS A 269
REMARK 465 ASN A 270
REMARK 465 VAL A 271
REMARK 465 ASP A 272
REMARK 465 LYS A 273
REMARK 465 TYR A 274
REMARK 465 LYS A 275
REMARK 465 ILE A 276
REMARK 465 ASN A 277
REMARK 465 TYR A 278
REMARK 465 GLU A 279
REMARK 465 ASN A 280
REMARK 465 ASN B 82
REMARK 465 LYS B 83
REMARK 465 GLU B 84
REMARK 465 THR B 85
REMARK 465 VAL B 86
REMARK 465 ASP B 87
REMARK 465 ASN B 88
REMARK 465 VAL B 89
REMARK 465 ASN B 90
REMARK 465 ASP B 91
REMARK 465 MET B 92
REMARK 465 MET B 233
REMARK 465 LEU B 234
REMARK 465 ASN B 235
REMARK 465 GLU B 236
REMARK 465 GLN B 237
REMARK 465 ASN B 238
REMARK 465 CYS B 239
REMARK 465 ILE B 240
REMARK 465 LYS B 241
REMARK 465 GLY B 242
REMARK 465 GLU B 243
REMARK 465 GLU B 244
REMARK 465 LYS B 245
REMARK 465 ASN B 246
REMARK 465 ASN B 247
REMARK 465 ASP B 248
REMARK 465 MET B 249
REMARK 465 PRO B 250
REMARK 465 LEU B 251
REMARK 465 LYS B 252
REMARK 465 ASN B 253
REMARK 465 ASP B 254
REMARK 465 ASP B 255
REMARK 465 LYS B 256
REMARK 465 ASP B 257
REMARK 465 THR B 258
REMARK 465 CYS B 259
REMARK 465 HIS B 260
REMARK 465 MET B 261
REMARK 465 LYS B 262
REMARK 465 LYS B 263
REMARK 465 LEU B 264
REMARK 465 THR B 265
REMARK 465 GLU B 266
REMARK 465 PHE B 267
REMARK 465 TYR B 268
REMARK 465 LYS B 269
REMARK 465 ASN B 270
REMARK 465 VAL B 271
REMARK 465 ASP B 272
REMARK 465 LYS B 273
REMARK 465 TYR B 274
REMARK 465 LYS B 275
REMARK 465 ILE B 276
REMARK 465 ASN B 277
REMARK 465 TYR B 278
REMARK 465 GLU B 279
REMARK 465 ASN B 280
REMARK 465 ASP C 281
REMARK 465 ASP C 282
REMARK 465 ASP D 281
REMARK 465 ASP D 282
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT
REMARK 500
REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT.
REMARK 500
REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE
REMARK 500 O HIS C 308 N ASN C 310 2.08
REMARK 500 O SER C 306 N HIS C 308 2.19
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: COVALENT BOND ANGLES
REMARK 500
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1)
REMARK 500
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996
REMARK 500
REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3
REMARK 500 GLY A 166 N - CA - C ANGL. DEV. = -20.3 DEGREES
REMARK 500 LYS B 27 N - CA - C ANGL. DEV. = 16.5 DEGREES
REMARK 500 PRO C 309 C - N - CD ANGL. DEV. = -13.1 DEGREES
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 SER A 22 74.97 -105.71
REMARK 500 LYS A 27 -95.88 -119.22
REMARK 500 LYS A 28 -100.68 -3.86
REMARK 500 ASN A 29 69.12 -119.46
REMARK 500 ARG A 38 -0.07 -146.65
REMARK 500 CYS A 50 117.64 -168.43
REMARK 500 ASN A 82 60.54 61.51
REMARK 500 TYR A 159 -75.34 -87.41
REMARK 500 ASP B 10 71.84 57.21
REMARK 500 SER B 22 9.12 -66.10
REMARK 500 LYS B 23 -53.80 92.49
REMARK 500 ASN B 24 16.75 161.82
REMARK 500 LYS B 27 -88.18 16.96
REMARK 500 ARG B 38 -25.14 -143.26
REMARK 500 GLU B 67 7.63 -63.04
REMARK 500 LYS B 79 5.76 -65.48
REMARK 500 SER B 95 35.11 71.59
REMARK 500 MET B 104 138.37 -170.41
REMARK 500 LYS B 114 -74.10 -57.57
REMARK 500 GLU B 134 -71.74 -61.34
REMARK 500 VAL B 140 90.64 -64.28
REMARK 500 LYS B 177 43.09 37.34
REMARK 500 GLU C 300 43.21 -84.78
REMARK 500 LYS C 304 -92.63 147.11
REMARK 500 ILE C 307 -13.96 45.89
REMARK 500 PRO C 309 26.84 -0.63
REMARK 500 PHE C 312 41.78 -97.74
REMARK 500 LYS C 321 75.55 -114.83
REMARK 500 TYR C 365 180.00 178.12
REMARK 500 TYR C 430 -67.05 -24.50
REMARK 500 THR C 442 -75.81 -113.85
REMARK 500 ASP C 500 55.98 39.60
REMARK 500 ALA C 541 -107.72 -104.83
REMARK 500 GLU D 285 -70.91 -49.95
REMARK 500 ASN D 303 33.43 -99.24
REMARK 500 HIS D 308 -6.27 74.55
REMARK 500 PRO D 309 -40.26 37.86
REMARK 500 PHE D 312 32.36 -92.48
REMARK 500 ARG D 345 -45.39 -18.19
REMARK 500 TYR D 365 164.32 179.65
REMARK 500 LEU D 418 60.24 -102.84
REMARK 500 ASN D 424 5.65 80.66
REMARK 500 TYR D 430 -63.92 -23.24
REMARK 500 THR D 442 -81.62 -106.79
REMARK 500 ASP D 500 55.17 39.31
REMARK 500 ALA D 541 -88.17 -113.08
REMARK 500 MET D 606 -5.27 -47.94
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE RJ6 A 609
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NDP A 610
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC3
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE UMP C 611
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC4
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE RJ6 B 609
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC5
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NDP B 610
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC6
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE UMP D 611
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 1J3I RELATED DB: PDB
REMARK 900 WILD-TYPE PLASMODIUM FALCIPARUM DIHYDROFOLATE REDUCTASE-THYMIDYLATE
REMARK 900 SYNTHASE (PFDHFR-TS) COMPLEXED WITH WR99210, NADPH, AND DUMP
REMARK 900 RELATED ID: 1J3J RELATED DB: PDB
REMARK 900 DOUBLE MUTANT (C59R,S108N) PLASMODIUM FALCIPARUM DIHYDROFOLATE
REMARK 900 REDUCTASE-THYMIDYLATE SYNTHASE (PFDHFR-TS) COMPLEXED WITH
REMARK 900 PYRIMETHAMINE, NADPH, AND DUMP
REMARK 900 RELATED ID: 1J3K RELATED DB: PDB
REMARK 900 QUADRUPLE MUTANT (N51I,C59R,S108N,I164L) PLASMODIUM FALCIPARUM
REMARK 900 DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE (PFDHFR-TS) COMPLEXED
REMARK 900 WITH WR99210, NADPH, AND DUMP
REMARK 900 RELATED ID: 3DGA RELATED DB: PDB
REMARK 900 WILD-TYPE PLASMODIUM FALCIPARUM DIHYDROFOLATE REDUCTASE-THYMIDYLATE
REMARK 900 SYNTHASE (PFDHFR-TS) COMPLEXED WITH RJF01302, NADPH, AND DUMP
REMARK 999
REMARK 999 SEQUENCE
REMARK 999 THE SEQUENCE INFORMATION PROVIDED BY AUTHORS IS
REMARK 999 THE GENBANK ENTRY ABU43156.1
DBREF 3DG8 A 1 280 UNP Q8I1R6 Q8I1R6_PLAF7 1 280
DBREF 3DG8 B 1 280 UNP Q8I1R6 Q8I1R6_PLAF7 1 280
DBREF 3DG8 C 281 608 UNP Q8I1R6 Q8I1R6_PLAF7 281 608
DBREF 3DG8 D 281 608 UNP Q8I1R6 Q8I1R6_PLAF7 281 608
SEQADV 3DG8 ILE A 51 UNP Q8I1R6 ASN 51 ENGINEERED MUTATION
SEQADV 3DG8 ARG A 59 UNP Q8I1R6 CYS 59 ENGINEERED MUTATION
SEQADV 3DG8 ASN A 108 UNP Q8I1R6 SER 108 ENGINEERED MUTATION
SEQADV 3DG8 LEU A 164 UNP Q8I1R6 ILE 164 ENGINEERED MUTATION
SEQADV 3DG8 ILE B 51 UNP Q8I1R6 ASN 51 ENGINEERED MUTATION
SEQADV 3DG8 ARG B 59 UNP Q8I1R6 CYS 59 ENGINEERED MUTATION
SEQADV 3DG8 ASN B 108 UNP Q8I1R6 SER 108 ENGINEERED MUTATION
SEQADV 3DG8 LEU B 164 UNP Q8I1R6 ILE 164 ENGINEERED MUTATION
SEQRES 1 A 280 MET MET GLU GLN VAL CYS ASP VAL PHE ASP ILE TYR ALA
SEQRES 2 A 280 ILE CYS ALA CYS CYS LYS VAL GLU SER LYS ASN GLU GLY
SEQRES 3 A 280 LYS LYS ASN GLU VAL PHE ASN ASN TYR THR PHE ARG GLY
SEQRES 4 A 280 LEU GLY ASN LYS GLY VAL LEU PRO TRP LYS CYS ILE SER
SEQRES 5 A 280 LEU ASP MET LYS TYR PHE ARG ALA VAL THR THR TYR VAL
SEQRES 6 A 280 ASN GLU SER LYS TYR GLU LYS LEU LYS TYR LYS ARG CYS
SEQRES 7 A 280 LYS TYR LEU ASN LYS GLU THR VAL ASP ASN VAL ASN ASP
SEQRES 8 A 280 MET PRO ASN SER LYS LYS LEU GLN ASN VAL VAL VAL MET
SEQRES 9 A 280 GLY ARG THR ASN TRP GLU SER ILE PRO LYS LYS PHE LYS
SEQRES 10 A 280 PRO LEU SER ASN ARG ILE ASN VAL ILE LEU SER ARG THR
SEQRES 11 A 280 LEU LYS LYS GLU ASP PHE ASP GLU ASP VAL TYR ILE ILE
SEQRES 12 A 280 ASN LYS VAL GLU ASP LEU ILE VAL LEU LEU GLY LYS LEU
SEQRES 13 A 280 ASN TYR TYR LYS CYS PHE ILE LEU GLY GLY SER VAL VAL
SEQRES 14 A 280 TYR GLN GLU PHE LEU GLU LYS LYS LEU ILE LYS LYS ILE
SEQRES 15 A 280 TYR PHE THR ARG ILE ASN SER THR TYR GLU CYS ASP VAL
SEQRES 16 A 280 PHE PHE PRO GLU ILE ASN GLU ASN GLU TYR GLN ILE ILE
SEQRES 17 A 280 SER VAL SER ASP VAL TYR THR SER ASN ASN THR THR LEU
SEQRES 18 A 280 ASP PHE ILE ILE TYR LYS LYS THR ASN ASN LYS MET LEU
SEQRES 19 A 280 ASN GLU GLN ASN CYS ILE LYS GLY GLU GLU LYS ASN ASN
SEQRES 20 A 280 ASP MET PRO LEU LYS ASN ASP ASP LYS ASP THR CYS HIS
SEQRES 21 A 280 MET LYS LYS LEU THR GLU PHE TYR LYS ASN VAL ASP LYS
SEQRES 22 A 280 TYR LYS ILE ASN TYR GLU ASN
SEQRES 1 B 280 MET MET GLU GLN VAL CYS ASP VAL PHE ASP ILE TYR ALA
SEQRES 2 B 280 ILE CYS ALA CYS CYS LYS VAL GLU SER LYS ASN GLU GLY
SEQRES 3 B 280 LYS LYS ASN GLU VAL PHE ASN ASN TYR THR PHE ARG GLY
SEQRES 4 B 280 LEU GLY ASN LYS GLY VAL LEU PRO TRP LYS CYS ILE SER
SEQRES 5 B 280 LEU ASP MET LYS TYR PHE ARG ALA VAL THR THR TYR VAL
SEQRES 6 B 280 ASN GLU SER LYS TYR GLU LYS LEU LYS TYR LYS ARG CYS
SEQRES 7 B 280 LYS TYR LEU ASN LYS GLU THR VAL ASP ASN VAL ASN ASP
SEQRES 8 B 280 MET PRO ASN SER LYS LYS LEU GLN ASN VAL VAL VAL MET
SEQRES 9 B 280 GLY ARG THR ASN TRP GLU SER ILE PRO LYS LYS PHE LYS
SEQRES 10 B 280 PRO LEU SER ASN ARG ILE ASN VAL ILE LEU SER ARG THR
SEQRES 11 B 280 LEU LYS LYS GLU ASP PHE ASP GLU ASP VAL TYR ILE ILE
SEQRES 12 B 280 ASN LYS VAL GLU ASP LEU ILE VAL LEU LEU GLY LYS LEU
SEQRES 13 B 280 ASN TYR TYR LYS CYS PHE ILE LEU GLY GLY SER VAL VAL
SEQRES 14 B 280 TYR GLN GLU PHE LEU GLU LYS LYS LEU ILE LYS LYS ILE
SEQRES 15 B 280 TYR PHE THR ARG ILE ASN SER THR TYR GLU CYS ASP VAL
SEQRES 16 B 280 PHE PHE PRO GLU ILE ASN GLU ASN GLU TYR GLN ILE ILE
SEQRES 17 B 280 SER VAL SER ASP VAL TYR THR SER ASN ASN THR THR LEU
SEQRES 18 B 280 ASP PHE ILE ILE TYR LYS LYS THR ASN ASN LYS MET LEU
SEQRES 19 B 280 ASN GLU GLN ASN CYS ILE LYS GLY GLU GLU LYS ASN ASN
SEQRES 20 B 280 ASP MET PRO LEU LYS ASN ASP ASP LYS ASP THR CYS HIS
SEQRES 21 B 280 MET LYS LYS LEU THR GLU PHE TYR LYS ASN VAL ASP LYS
SEQRES 22 B 280 TYR LYS ILE ASN TYR GLU ASN
SEQRES 1 C 328 ASP ASP ASP ASP GLU GLU GLU ASP ASP PHE VAL TYR PHE
SEQRES 2 C 328 ASN PHE ASN LYS GLU LYS GLU GLU LYS ASN LYS ASN SER
SEQRES 3 C 328 ILE HIS PRO ASN ASP PHE GLN ILE TYR ASN SER LEU LYS
SEQRES 4 C 328 TYR LYS TYR HIS PRO GLU TYR GLN TYR LEU ASN ILE ILE
SEQRES 5 C 328 TYR ASP ILE MET MET ASN GLY ASN LYS GLN SER ASP ARG
SEQRES 6 C 328 THR GLY VAL GLY VAL LEU SER LYS PHE GLY TYR ILE MET
SEQRES 7 C 328 LYS PHE ASP LEU SER GLN TYR PHE PRO LEU LEU THR THR
SEQRES 8 C 328 LYS LYS LEU PHE LEU ARG GLY ILE ILE GLU GLU LEU LEU
SEQRES 9 C 328 TRP PHE ILE ARG GLY GLU THR ASN GLY ASN THR LEU LEU
SEQRES 10 C 328 ASN LYS ASN VAL ARG ILE TRP GLU ALA ASN GLY THR ARG
SEQRES 11 C 328 GLU PHE LEU ASP ASN ARG LYS LEU PHE HIS ARG GLU VAL
SEQRES 12 C 328 ASN ASP LEU GLY PRO ILE TYR GLY PHE GLN TRP ARG HIS
SEQRES 13 C 328 PHE GLY ALA GLU TYR THR ASN MET TYR ASP ASN TYR GLU
SEQRES 14 C 328 ASN LYS GLY VAL ASP GLN LEU LYS ASN ILE ILE ASN LEU
SEQRES 15 C 328 ILE LYS ASN ASP PRO THR SER ARG ARG ILE LEU LEU CYS
SEQRES 16 C 328 ALA TRP ASN VAL LYS ASP LEU ASP GLN MET ALA LEU PRO
SEQRES 17 C 328 PRO CYS HIS ILE LEU CYS GLN PHE TYR VAL PHE ASP GLY
SEQRES 18 C 328 LYS LEU SER CYS ILE MET TYR GLN ARG SER CYS ASP LEU
SEQRES 19 C 328 GLY LEU GLY VAL PRO PHE ASN ILE ALA SER TYR SER ILE
SEQRES 20 C 328 PHE THR HIS MET ILE ALA GLN VAL CYS ASN LEU GLN PRO
SEQRES 21 C 328 ALA GLN PHE ILE HIS VAL LEU GLY ASN ALA HIS VAL TYR
SEQRES 22 C 328 ASN ASN HIS ILE ASP SER LEU LYS ILE GLN LEU ASN ARG
SEQRES 23 C 328 ILE PRO TYR PRO PHE PRO THR LEU LYS LEU ASN PRO ASP
SEQRES 24 C 328 ILE LYS ASN ILE GLU ASP PHE THR ILE SER ASP PHE THR
SEQRES 25 C 328 ILE GLN ASN TYR VAL HIS HIS GLU LYS ILE SER MET ASP
SEQRES 26 C 328 MET ALA ALA
SEQRES 1 D 328 ASP ASP ASP ASP GLU GLU GLU ASP ASP PHE VAL TYR PHE
SEQRES 2 D 328 ASN PHE ASN LYS GLU LYS GLU GLU LYS ASN LYS ASN SER
SEQRES 3 D 328 ILE HIS PRO ASN ASP PHE GLN ILE TYR ASN SER LEU LYS
SEQRES 4 D 328 TYR LYS TYR HIS PRO GLU TYR GLN TYR LEU ASN ILE ILE
SEQRES 5 D 328 TYR ASP ILE MET MET ASN GLY ASN LYS GLN SER ASP ARG
SEQRES 6 D 328 THR GLY VAL GLY VAL LEU SER LYS PHE GLY TYR ILE MET
SEQRES 7 D 328 LYS PHE ASP LEU SER GLN TYR PHE PRO LEU LEU THR THR
SEQRES 8 D 328 LYS LYS LEU PHE LEU ARG GLY ILE ILE GLU GLU LEU LEU
SEQRES 9 D 328 TRP PHE ILE ARG GLY GLU THR ASN GLY ASN THR LEU LEU
SEQRES 10 D 328 ASN LYS ASN VAL ARG ILE TRP GLU ALA ASN GLY THR ARG
SEQRES 11 D 328 GLU PHE LEU ASP ASN ARG LYS LEU PHE HIS ARG GLU VAL
SEQRES 12 D 328 ASN ASP LEU GLY PRO ILE TYR GLY PHE GLN TRP ARG HIS
SEQRES 13 D 328 PHE GLY ALA GLU TYR THR ASN MET TYR ASP ASN TYR GLU
SEQRES 14 D 328 ASN LYS GLY VAL ASP GLN LEU LYS ASN ILE ILE ASN LEU
SEQRES 15 D 328 ILE LYS ASN ASP PRO THR SER ARG ARG ILE LEU LEU CYS
SEQRES 16 D 328 ALA TRP ASN VAL LYS ASP LEU ASP GLN MET ALA LEU PRO
SEQRES 17 D 328 PRO CYS HIS ILE LEU CYS GLN PHE TYR VAL PHE ASP GLY
SEQRES 18 D 328 LYS LEU SER CYS ILE MET TYR GLN ARG SER CYS ASP LEU
SEQRES 19 D 328 GLY LEU GLY VAL PRO PHE ASN ILE ALA SER TYR SER ILE
SEQRES 20 D 328 PHE THR HIS MET ILE ALA GLN VAL CYS ASN LEU GLN PRO
SEQRES 21 D 328 ALA GLN PHE ILE HIS VAL LEU GLY ASN ALA HIS VAL TYR
SEQRES 22 D 328 ASN ASN HIS ILE ASP SER LEU LYS ILE GLN LEU ASN ARG
SEQRES 23 D 328 ILE PRO TYR PRO PHE PRO THR LEU LYS LEU ASN PRO ASP
SEQRES 24 D 328 ILE LYS ASN ILE GLU ASP PHE THR ILE SER ASP PHE THR
SEQRES 25 D 328 ILE GLN ASN TYR VAL HIS HIS GLU LYS ILE SER MET ASP
SEQRES 26 D 328 MET ALA ALA
HET RJ6 A 609 17
HET NDP A 610 48
HET RJ6 B 609 17
HET NDP B 610 48
HET UMP C 611 20
HET UMP D 611 20
HETNAM RJ6 N-(3,5-DIMETHOXYPHENYL)IMIDODICARBONIMIDIC DIAMIDE
HETNAM NDP NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE
HETNAM 2 NDP PHOSPHATE
HETNAM UMP 2'-DEOXYURIDINE 5'-MONOPHOSPHATE
HETSYN RJ6 {[(3,5-DIMETHOXYANILINO)(IMINO)
HETSYN 2 RJ6 METHYL]AMINO}METHANIMIDAMIDE
HETSYN UMP DUMP
FORMUL 5 RJ6 2(C10 H15 N5 O2)
FORMUL 6 NDP 2(C21 H30 N7 O17 P3)
FORMUL 9 UMP 2(C9 H13 N2 O8 P)
FORMUL 11 HOH *260(H2 O)
HELIX 1 1 GLN A 4 PHE A 9 1 6
HELIX 2 2 ASN A 33 TYR A 35 5 3
HELIX 3 3 ILE A 51 TYR A 64 1 14
HELIX 4 4 ASN A 66 LEU A 81 1 16
HELIX 5 5 ARG A 106 SER A 111 1 6
HELIX 6 6 PRO A 113 LYS A 117 5 5
HELIX 7 7 LYS A 132 PHE A 136 5 5
HELIX 8 8 LYS A 145 LEU A 156 1 12
HELIX 9 9 GLY A 166 LYS A 176 1 11
HELIX 10 10 GLN B 4 ASP B 10 1 7
HELIX 11 11 ASN B 33 TYR B 35 5 3
HELIX 12 12 ILE B 51 TYR B 64 1 14
HELIX 13 13 TYR B 70 CYS B 78 1 9
HELIX 14 14 LYS B 79 LEU B 81 5 3
HELIX 15 15 ARG B 106 ILE B 112 1 7
HELIX 16 16 GLU B 147 LYS B 155 1 9
HELIX 17 17 GLY B 166 LYS B 176 1 11
HELIX 18 18 GLU C 285 ASN C 294 1 10
HELIX 19 19 PRO C 309 ASP C 311 5 3
HELIX 20 20 PHE C 312 LEU C 318 1 7
HELIX 21 21 PRO C 324 GLY C 339 1 16
HELIX 22 22 LEU C 376 GLY C 389 1 14
HELIX 23 23 ASN C 392 ASN C 398 1 7
HELIX 24 24 GLU C 405 GLY C 408 5 4
HELIX 25 25 THR C 409 ARG C 416 1 8
HELIX 26 26 ILE C 429 PHE C 437 1 9
HELIX 27 27 ASP C 454 ASP C 466 1 13
HELIX 28 28 ASP C 481 MET C 485 5 5
HELIX 29 29 LEU C 516 CYS C 536 1 21
HELIX 30 30 HIS C 556 ASN C 565 1 10
HELIX 31 31 ASN C 582 PHE C 586 5 5
HELIX 32 32 THR C 587 SER C 589 5 3
HELIX 33 33 ASP D 283 ASN D 294 1 12
HELIX 34 34 ASN D 303 HIS D 308 1 6
HELIX 35 35 PRO D 309 ASP D 311 5 3
HELIX 36 36 PHE D 312 LEU D 318 1 7
HELIX 37 37 GLU D 325 GLY D 339 1 15
HELIX 38 38 LEU D 376 ARG D 388 1 13
HELIX 39 39 ASN D 392 ASN D 398 1 7
HELIX 40 40 GLU D 405 GLY D 408 5 4
HELIX 41 41 THR D 409 ARG D 416 1 8
HELIX 42 42 ILE D 429 PHE D 437 1 9
HELIX 43 43 ASP D 454 ASP D 466 1 13
HELIX 44 44 ASP D 481 MET D 485 5 5
HELIX 45 45 LEU D 516 CYS D 536 1 21
HELIX 46 46 HIS D 556 ASN D 565 1 10
HELIX 47 47 THR D 587 SER D 589 5 3
SHEET 1 A 8 TYR A 141 ILE A 143 0
SHEET 2 A 8 ILE A 123 LEU A 127 1 N ILE A 126 O TYR A 141
SHEET 3 A 8 VAL A 101 GLY A 105 1 N VAL A 102 O VAL A 125
SHEET 4 A 8 CYS A 161 GLY A 165 1 O PHE A 162 N VAL A 101
SHEET 5 A 8 ILE A 11 VAL A 20 1 N TYR A 12 O CYS A 161
SHEET 6 A 8 LYS A 181 TYR A 191 1 O THR A 185 N CYS A 17
SHEET 7 A 8 THR A 219 LYS A 228 -1 O ILE A 224 N PHE A 184
SHEET 8 A 8 TYR A 214 SER A 216 -1 N SER A 216 O THR A 219
SHEET 1 B 7 VAL A 195 PHE A 196 0
SHEET 2 B 7 PHE A 37 GLY A 41 -1 N LEU A 40 O VAL A 195
SHEET 3 B 7 ILE A 11 VAL A 20 -1 N CYS A 18 O GLY A 39
SHEET 4 B 7 LYS A 181 TYR A 191 1 O THR A 185 N CYS A 17
SHEET 5 B 7 THR A 219 LYS A 228 -1 O ILE A 224 N PHE A 184
SHEET 6 B 7 TYR A 205 VAL A 210 -1 N GLN A 206 O LYS A 227
SHEET 7 B 7 TYR C 320 LYS C 321 1 O TYR C 320 N VAL A 210
SHEET 1 C 8 TYR B 141 ILE B 143 0
SHEET 2 C 8 ILE B 123 LEU B 127 1 N ILE B 126 O ILE B 143
SHEET 3 C 8 GLN B 99 GLY B 105 1 N ASN B 100 O ILE B 123
SHEET 4 C 8 TYR B 158 ILE B 163 1 O PHE B 162 N VAL B 101
SHEET 5 C 8 ILE B 11 LYS B 19 1 N TYR B 12 O ILE B 163
SHEET 6 C 8 LYS B 181 THR B 190 1 O TYR B 183 N CYS B 15
SHEET 7 C 8 THR B 220 LYS B 228 -1 O ILE B 224 N PHE B 184
SHEET 8 C 8 TYR B 214 THR B 215 -1 N TYR B 214 O LEU B 221
SHEET 1 D 7 VAL B 195 PHE B 196 0
SHEET 2 D 7 PHE B 37 GLY B 41 -1 N LEU B 40 O VAL B 195
SHEET 3 D 7 ILE B 11 LYS B 19 -1 N CYS B 18 O ARG B 38
SHEET 4 D 7 LYS B 181 THR B 190 1 O TYR B 183 N CYS B 15
SHEET 5 D 7 THR B 220 LYS B 228 -1 O ILE B 224 N PHE B 184
SHEET 6 D 7 TYR B 205 VAL B 210 -1 N ILE B 208 O ILE B 225
SHEET 7 D 7 TYR D 320 LYS D 321 1 O TYR D 320 N VAL B 210
SHEET 1 E 6 ASN C 340 SER C 343 0
SHEET 2 E 6 GLY C 349 ASP C 361 -1 O VAL C 350 N GLN C 342
SHEET 3 E 6 GLN C 539 TYR C 553 -1 O LEU C 547 N TYR C 356
SHEET 4 E 6 LYS C 502 ASP C 513 1 N CYS C 505 O ILE C 544
SHEET 5 E 6 HIS C 491 PHE C 499 -1 N GLN C 495 O ILE C 506
SHEET 6 E 6 LEU C 473 CYS C 475 -1 N LEU C 474 O CYS C 494
SHEET 1 F 2 THR C 573 LEU C 576 0
SHEET 2 F 2 PHE C 591 GLN C 594 -1 O THR C 592 N LYS C 575
SHEET 1 G 6 ASN D 340 ASP D 344 0
SHEET 2 G 6 VAL D 348 ASP D 361 -1 O VAL D 350 N GLN D 342
SHEET 3 G 6 GLN D 539 TYR D 553 -1 O HIS D 545 N MET D 358
SHEET 4 G 6 LYS D 502 ASP D 513 1 N CYS D 505 O ILE D 544
SHEET 5 G 6 HIS D 491 PHE D 499 -1 N GLN D 495 O ILE D 506
SHEET 6 G 6 LEU D 473 CYS D 475 -1 N LEU D 474 O CYS D 494
SHEET 1 H 2 THR D 573 LEU D 576 0
SHEET 2 H 2 PHE D 591 GLN D 594 -1 O THR D 592 N LYS D 575
CISPEP 1 LYS A 117 PRO A 118 0 -0.22
CISPEP 2 LYS B 117 PRO B 118 0 0.04
SITE 1 AC1 11 ILE A 14 CYS A 15 LEU A 46 ASP A 54
SITE 2 AC1 11 PHE A 58 ASN A 108 ILE A 112 LEU A 119
SITE 3 AC1 11 LEU A 164 TYR A 170 NDP A 610
SITE 1 AC2 27 CYS A 15 ALA A 16 LEU A 40 GLY A 44
SITE 2 AC2 27 VAL A 45 GLY A 105 ARG A 106 THR A 107
SITE 3 AC2 27 ASN A 108 LEU A 127 SER A 128 ARG A 129
SITE 4 AC2 27 THR A 130 ASN A 144 VAL A 146 LEU A 164
SITE 5 AC2 27 GLY A 165 GLY A 166 SER A 167 VAL A 168
SITE 6 AC2 27 VAL A 169 TYR A 170 GLU A 172 VAL A 195
SITE 7 AC2 27 RJ6 A 609 HOH A1073 HOH A1151
SITE 1 AC3 14 ARG C 345 CYS C 490 HIS C 491 GLN C 509
SITE 2 AC3 14 ARG C 510 SER C 511 ASP C 513 GLY C 517
SITE 3 AC3 14 ASN C 521 HIS C 551 TYR C 553 HOH C1048
SITE 4 AC3 14 ARG D 470 ARG D 471
SITE 1 AC4 10 ILE B 14 LEU B 46 ASP B 54 PHE B 58
SITE 2 AC4 10 ASN B 108 ILE B 112 LEU B 119 LEU B 164
SITE 3 AC4 10 TYR B 170 NDP B 610
SITE 1 AC5 23 CYS B 15 ALA B 16 LEU B 40 GLY B 44
SITE 2 AC5 23 GLY B 105 ARG B 106 THR B 107 ASN B 108
SITE 3 AC5 23 LEU B 127 SER B 128 ARG B 129 THR B 130
SITE 4 AC5 23 ASN B 144 LYS B 145 LEU B 164 GLY B 165
SITE 5 AC5 23 GLY B 166 SER B 167 VAL B 168 VAL B 169
SITE 6 AC5 23 TYR B 170 GLU B 172 RJ6 B 609
SITE 1 AC6 12 ARG C 470 ARG C 471 CYS D 490 HIS D 491
SITE 2 AC6 12 GLN D 509 ARG D 510 SER D 511 ASP D 513
SITE 3 AC6 12 GLY D 517 ASN D 521 HIS D 551 TYR D 553
CRYST1 56.516 155.404 165.183 90.00 90.00 90.00 P 21 21 21 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.017694 0.000000 0.000000 0.00000
SCALE2 0.000000 0.006435 0.000000 0.00000
SCALE3 0.000000 0.000000 0.006054 0.00000